Shares in DARA BioSciences (DARA +8.7%) get a boost today, after commenting earlier that its...

|By:, SA News Editor

Shares in DARA BioSciences (DARA +8.7%) get a boost today, after commenting earlier that its investigational drug KRN5500 has been granted a fast-track designation by the FDA to treat chemotherapy-induced neuropathic pain in cancer patients.